ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • T and B Cell Response to 3 Dose Covid Vaccine Series for Kidney Transplant Patients on Belatacept

    J. Christensen1, I. Yakubu2, D. Kumar1, D. Cornett3, M. A. Miller3, M. Altrich3, L. Flebbe-Rehwaldt3, R. Thompson1, G. Gupta1

  • T Cell Overexpression of PD-1 Increases Treg Suppressive Function via an ICOS-Dependent Mechanism

    T. J. Borges1, N. Murakami2, I. T. Lape1, R. B. Gassen1, K. Liu1, L. V. Riella1

  • T Cell-Specific CEACAM1 Alleviates Posttransplant Liver Injury via TIM-3 Inhibitory Regulation

    H. Kojima, H. Hirao, K. Kadono, T. Ito, K. J. Dery, F. Kaldas, J. Kupiec-Weglinski

  • T-cell Depletion vs. Il-2 Receptor Blockade in Pancreas Transplantationt-Cell Depletion vs. Il-2 Receptor Blockade in Pancreas Transplantation

    F. Aziz, S. Parajuli, D. Kaufman, J. Odorico, D. Mandelbrot

  • Tabelecleucel (Tab-cel) for Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplant (HCT) Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure Of Rituximab (R) ± Chemotherapy (CT) (ALLELE)

    S. Prockop1, A. Beitinjaneh2, S. Choquet3, S. Dahiya4, R. Dinavahi5, R. Farah6, L. Gamelin5, A. Joshi5, A. Mehta5, P. Nayak5, R. Reshef7, G. Satyanarayana8, P. Stiff9, W. Ye5, K. M. Mahadeo10

  • Tacrolimus After Rabbit Antithymocyte Globulin And Infliximab Induction Immunosuppression In Kidney Transplantation

    O. Viklicky1, G. Bold2, O. Bestard3, P. Hruba1, I. Zahradka1, N. M. Otto2, M. Stein2, A. Sefrin2, S. Christakoudi4, P. M. Reinke2

  • Tacrolimus and Mycophenolic Acid Therapeutic Exposure Targets in Black and White Kidney Transplant Recipients

    K. Tornatore1, K. Attwood1, S. Chang1, A. Gundroo2, B. Murray1

  • Tacrolimus Exposure Estimation in Stable Kidney Transplant Recipients Using Maximum A Posteriori Bayesian Approach

    T. Nguyen1, N. M. Smith1, K. Attwood2, B. Murray3, K. Tornatore-Morse1

  • Tacrolimus Induces Dedifferentiation of Pancreatic Beta Cells by Inhibition of Calcineurin/NFATc2 and Islet Cell Differentiation Genes

    C. M. Darden1, S. Vasu2, J. Mattke3, Y. Liu2, B. Naziruddin4, M. C. Lawrence2

  • Tacrolimus Metabolizer Heterogeneity within Caucasian Kidney Transplant (KT) Recipients

    J. Sanchez-Garcia1, N. Oliver1, D. Morris1, A. Raza1, L. Lindberg1, S. LeCorhick1, T. Srinivas2, S. Anand1

  • Targeted Delivery of Costimulation Inhibitor to Lymph Nodes Promotes Transplant Tolerance via Fibroblastic Reticular Cells

    J. Zhao1, S. Jung1, X. Li1, H. Zhang1, S. Movahedi1, V. Kasinath1, M. Uehara1, J. Azzi1, P. Sage1, S. Tullius1, J. S. Bromberg2, R. Abdi1

  • Targeting the Bet Family Protein Brd4 Inhibits Inflammatory Macrophages and Promotes Heart Allograft Tolerance

    X. Xiao

  • TCMR in Late Kidney Transplant Biopsies Shows Less Molecular TCMR Activity and More Fibrosis Despite Persistence of Tubulitis and Interstitial Infiltrate

    K. S. Madill-Thomsen1, J. Reeve1, P. Halloran1, .. and the INTERCOMEX Study Group2

  • Team Decision-Making in Liver Transplant Evaluation: A Multi-Center Ethnographic Observation Study

    C. N. Sidoti, H. C. Sung, D. L. Segev, M. L. Levan, T. S. Purnell, A. T. Strauss

  • Technical Report to Increased Utilization of Injured Kidneys: CT Scan to Evaluate Organ and Reduce Discard

    V. E. Whittaker

  • Technology Enabled And Molecular Monitoring Of The Allograft And Transplant Recipient Study

    N. Sulejmani1, D. Axelrod2, S. Dholakia1, S. Shah3

  • Technology-Driven Performance Improvement of a Biomarker Panel in Kidney Transplant: OmniGraf

    P. West-Thielke, C. Miller, N. Grund, A. Sutton, R. Sinha, M. Miller, S. Kleiboeker, J. Weems

  • Tele-Health Implementation During Covid19 Pandemic in Liver Transplant Population: A Focus on Medication Adherence, Patient Satisfaction, Clinical Outcomes and Possible Cost Impact

    H. Joharji, S. Alghamdi, S. Alqahtani, M. F. Janju, J. Khader, D. Alissa, A. Aljedai, D. Alkortas, K. Bezaizi, D. Broering, A. Ajlan, W. K. Al-Hamoudi, E. Devol, A. Albinmosa, S. Alabbad, Z. Alabdulkarim, A. Zidan, R. Alamawi, E. Alshammari, E. Alharthi, D. Al-Anazi, A. Almalki, M. Alasmari

  • Telemedical Surveillance and Optimized Treatment of Blood Pressure in Kidney Transplant Recipients

    W. Düttmann1, M. G. Naik1, B. Zukunft1, B. Osmanodja1, G. Eleftheriadis1, S. Ronicke2, M. Choi1, F. Bachmann1, F. Halleck1, K. Budde1

  • Telemedicine Implementation in Solid Organ Transplant (SOT) Clinics is Associated with Satisfaction Among Patients and Providers but Increased Burden on Staff

    C. W. Wang, N. Ha, M. Duarte, C. B. Sherman

  • Telemedicine Services for Living Kidney Donation: A U.S. Survey of Multidisciplinary Providers

    F. Al Ammary1, J. Motter1, H. Sung1, K. Lentine2, A. Sharfuddin3, V. Kumar4, A. Yadav5, M. Doshi6, S. Virmani7, B. Concepcion8, T. Grace9, C. Sidoti1, M. Y. Jon3, A. Muzaale1, J. Wolf10

  • Temporal Changes in the Peripheral Immune Profile of Acute Rejection Highlight New Mechanisms of Alloimmunity and Potential Non-Invasive Biomarkers of Rejection in Pediatric Liver Transplantation

    D. N. Sarode1, B. Rocque1, A. Barbetta1, P. Singh1, C. Goldbeck1, C. Weaver2, O. Akbari1, R. Kohli2, J. Emamaullee1

  • Temporal Trends in Utilization, Discard, and Outcomes for Extended Criteria Donor Lungs

    A. Hallett1, L. Zeiser1, W. Lightle2, J. Ruck1, J. Alejo1, A. Massie1, D. Segev1

  • Temporal Trends of Optn Hope Act Variance Participation

    A. Wilk1, M. Green2, C. Marsh3, N. Theodoropoulos4, R. Formica5, N. Turgeon6, A. Fox7, A. Wilhelm1, D. Klassen1

  • Temporary Donor Splenic Transplant (Splenopheresis) in Simultaneous Kidney Transplant Provides a Safe Immunologic Window in Sensitized Patients

    P. Di Cocco1, S. Gaitonde2, M. Spaggiari3, A. M. Fratti3, S. Akshelyan3, A. Jorge1, E. Benedetti3, I. Tzvetanov3

  • TEMRA CD8 T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2x4 Receptor-Dependent Proinflammatory and Migratory Responses

    G. Tilly1, T. Doan-Ngoc1, O. Bonizec1, C. Masset2, R. Danger3, P. Guérif1, S. Bruneau1, J. Harb1, M. Giral1, C. Pecqueur4, S. Brouard1, N. Degauque1

  • Testing an Education Only Intervention to Increase Willingness and Pursuit of Living Donor Kidney Transplantation

    J. Loor1, Y. Leyva1, E. Croswell2, M. Dew2, L. Boulware3, L. Myaskovsky1

  • Textbook Outcome in Lung Transplantation: Planned VA ECMO versus Off-Pump

    S. E. Halpern1, M. C. Wright2, G. Madsen2, B. Chow2, J. C. Haney3, J. A. Klapper3, B. A. Bottiger2, M. G. Hartwig3

  • The Acuity Circle Allocation Policy is Associated with Worse Graft Survival After Liver Transplant with Donation After Circulatory Death Donors in Low-MELD Centers

    T. Kitajima1, T. Ivanics2, D. Moonka1, M. Shamaa1, A. Mohamed3, S. Shimada1, K. Collins4, M. Rizzari1, A. Yoshida1, M. Abouljoud4, S. Nagai1

  • The Addition of Bortezomib to a Rituximab Based Antibody Mediated Rejection Treatment Protocol in Lung Transplant

    M. Galle, P. Stracener, K. Warrior, J. Lyons

  • The Application of Activated Stem Cells from Human Exfoliated Deciduous Teeth (SHED) in Islet Transplantation for Novel Immunosuppressive Therapy

    K. Ishiyama1, M. Kato2, S. Tsunekawa2, Y. Miwa1, K. Iwasaki1, H. Kamiya2, T. Kobayashi1

  • The Association Between Renal Anatomy Data and Kidney Utilization

    A. M. Placona, C. Martinez, K. McCharen, B. Shean, M. Stuart

  • The Association of Pre-Transplant Dialysis Time and the Survival Benefit of Deceased Donor Kidney Transplantation

    W. F. Parker1, Y. Becker2, R. Gibbons1

  • The Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals

    R. Gruessner, J. Renz, A. C. Gruessner

  • The Correlation Between Kidney Donor Risk Index, Kidney Graft Function and Histological Changes in Early Post-Transplant Renal Biopsy

    N. Slabiak-Blaz, A. Kujawa-Szewieczek, A. Kolonko, H. Karkoszka, A. Wiecek, G. Piecha

  • The Correlation of Dd-cfdna and Donor Specific Antibodies in Kidney Transplant Recipients

    S. Kant, T. Ishaque, A. Massie, D. C. Brennan, M. Bettinotti

  • The Cost And Logistical Challenges To Kidney Paired Donation

    S. G. Yi1, V. E. Whittaker2, T. B. Dunn3, N. Goldaracena4, V. Humphreville5, C. Kubal6, C. Kuhr7, D. Leeser8, J. Pomposelli9, E. Thomas10, N. Turgeon11, C. Varma12, M. Rees13, A. K. Mathur14

  • The Cost of Procuring Deceased Donor Livers: Evidence from OPO Cost Reports 2013-2018

    J. Bragg-Gresham1, T. Peters2, F. McCormick3, J. Roberts4

  • The Development of a Scientific Registry of Transplant Recipients Data Query Tool: A Human-Centered Design Process

    C. Schaffhausen1, A. Hart2, C. S. Zinner3, A. K. Israni2, J. Snyder1

  • The Effect of Adoption of Acuity Circles on Hepatocellular Carcinoma Transplantation Rates at a Single High Acuity Center

    D. W. Victor III, J. Corkrean, S. Kodali

  • The Effect of Bariatric Surgery Pre-Transplant on Renal Transplant Outcomes

    R. Zaminpeyma, S. Negi, N. Saberi, A. Andalib, S. Paraskevas, J. Tchervenkov

  • The Effect of Baseline Blood Pressure on Early Graft Function in Deceased Donor Kidney Transplantation

    B. Jun Bae1, C. Oh1, H. Ahn2

  • The Effect of COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients – International Multicenter Survey

    M. Segovia1, M. Fernandez2, S. Jafri3, T. Schiano4, S. Horslen5, C. Rumbo2, C. Zanfi6, A. Testro7, L. Sharkey8, F. Braun9, H. Vilca Melendez10, R. Sanchez Claria11, L. Ceulemans12, T. Hibi13, D. Ramish2, G. Noel1, G. Dijkstra14, P. Friend15, F. Lacaille16, D. Sudan1, G. Mazariegos17, J. Yap18, G. Herlenius19, H. Solar2, G. Gondolesi2

  • The Effect of Donor-Recipient Race and Ethnicity Match on Liver Transplantation Outcome in the United States

    H. Liu, C. Kaltenmeier, R. Cruz, A. M. Thompson, D. Reddy, M. D'Alesio, S. Lebowitz, E. Ashwat, S. Tohme, D. Geller, A. Tevar, C. Hughes, A. Humar, M. Molinari

  • The Effect of Including Race Adjustment in EGFR for Black Living Kidney Donors

    A. Henderson, A. Robinson, S. Noreen, L. A. Cartwright, T. G. Mupfudze, W. S. Cherikh, D. Klassen, J. Wainright

  • The Effect of Late-Onset Cytomegalovirus Infection on the Outcome of Renal Allograft in Patients with Delayed Graft Function

    M. Rahimi Shahmirzadi1, M. Silverman1, L. Gunaratnam2, A. Jevnikar2, A. A. House2, S. Hosseini-Moghaddam3

  • The Effect of Tacrolimus and Mycophenolic Acid on Torque Teno Virus Loads in Kidney Transplant Recipients

    A. van Rijn, S. Meziyerh, D. van der Helm, T. van Gelder, A. Kroes, J. de Fijter, D. Moes, J. Rotmans, A. de Vries, M. Feltkamp

  • The Effectiveness of Healthcare-Associated Infections Prevention Measures in the Incidence of Infections and In-Hospital Mortality After Liver Transplantation: A Quasi-Experimental Single-Center Study

    C. Bittante1, L. R. Requião-Moura2, F. Menezes1, S. Morgado1, L. Correa3, L. Camargo2

  • The Effects of Race-Matching in Small Intestine Transplantation

    C. G. Yergin1, C. Warren2, S. Duarte3, T. Beduschi4, A. Zarrinpar5

  • The Enhanced Recovery After Surgery (ERAS) Program for Donor Hepatectomy; Useful Method for Donor Safety? Or Unnecessary Hindrance?

    H. Choi1, G. Na2, H. Park1, Y. Woo1, Y. Choi1, S. Park1, Y. You1

  • The Evolution of Hypogammaglobulinemia in Kidney Transplant Recipients and Its Associated Risk Factors

    E. Jo1, S. Min2, A. Han3

  • The Evolution of Mortality in Kidney Transplant Recipients at a Single Center in the Era of Covid

    M. M. Eiting, K. Phillips, L. Smith

  • The Feasibility of Changing HCC MELD Exception Criteria to an Exclusive DCD-Only Option: A Strategy to Increase DCD Utilization

    G. J. McKenna, P. Schultz, M. Finotti, M. Rosenzweig, A. Gupta, S. H. Lee, A. Wall, E. Martinez, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa

  • The Financial Burden Of Transplant – A Commercial Claims Analysis

    G. Katz-Greenberg1, O. Osazuwa-Peters1, J. Gonzalez1, S. Sanoff1, O. Oloruntoba1, N. Chan1, E. J. Gordon2, C. Scales1, A. Brookhart1, L. McElroy1

  • The Gift of Life: Gift Discourse in Transplant and Its Implications in Anonymous Living Liver Donation

    S. S. Humar1, J. Jung2, S. Krause1, N. Selzner1, S. Abbey1

  • The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation

    M. Dela Cruz1, H. Lin2, E. Adler2, M. Khalid2, J. Boissiere2, G. Kim1, S. Pinney1, E. Pamer2, A. Nguyen1

  • The High Acuity Index: A Posttransplant Prediction Score for High-MELD Patients

    C. R. Christmann1, A. Anand1, G. Handing1, A. Rana2

  • The High Incidence of Long-COVID-19 in Kidney Transplant Recipients: A Longitudinal Cohort Study

    V. Lafico Teixeira Gomes, P. Quintino, H. Tedesco, J. Medina, C. Eduardo Neves Amorim, M. Cristelli

  • The Higher Cost of Donation After Circulatory Death Liver Transplantation Starts with Acquisition Costs: A Single Center Comparison Liver Acquisition Fees by Donor Type

    V. Reddy1, S. Asrani2, J. Trotter2, R. Ruiz3, S. Lee2, E. Martinez2, N. Onaca2, G. McKenna4, A. Gupta2, H. Fernandez2, J. Bayer2, G. Testa2, A. Wall2

  • The Impact Of Covid-19 On Pediatric Organ Donation And Transplantation

    E. Lee1, X. Zhang2, G. Mazariegos3, T. Nakagawa4

  • The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study

    R. D. Foresto1, H. Fagundes2, V. Lafico2, H. Tedesco Silva Junior2, M. P. Cristelli1, J. Pestana1

  • The Impact of Donor Nephrectomy on the Living Donors Aged 75 Years and Older

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, N. Goto, T. Ichimori, S. Narumi, Y. Watarai

  • The Impact of Donor’s Metabolic Syndrome Factor on Living Kidney Transplantation

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

  • The Impact of Early Graft Infiltrating TCF-1LowPD-1HighCD8+ T Cells in Delayed Fc Nonbinding Anti-CD3 Antibody Protocol in the Sensitized Mouse Model

    T. Ota1, R. Goto1, T. Harada1, Y. Ganchiku1, M. Zaitsu1, A. Forgioni1, N. Kawamura2, M. Watanabe2, M. Fukai1, T. Shimamura3, A. Taketomi1

  • The Impact of Food Insecurity on Pediatric Kidney Transplant Outcomes

    A. Moin, J. Krissberg, D. Matossian, P. Verghese

  • The Impact of Frailty Syndrome on Humoral Response to SARS-CoV-2 mRNA Vaccines in Older Kidney Transplant Recipients

    M. Schmalz1, H. Vankova2, S. Rajnochova-Bloudickova1, P. Hruba3, M. Fialova4, J. Gurka5, M. Magicova1, I. Striz4, I. Zahradka1, O. Viklicky1

  • The Impact of Having Potential Living Donors on Patients’ Access to Kidney Transplantation

    E. J. Gordon1, J. Lee1, R. Kang1, J. Caicedo2

  • The Impact of Long-Term Exposure to Tacrolimus on Chronic Kidney Disease Following Lung Transplantation: A Retrospective Analysis from a Single Transplantation Center

    D. Xiong, J. Zhang, J. Chen

  • The Impact of Maintenance Immunosuppressive Regimen on COVID-19 Outcomes Among Kidney Transplant Patients

    T. V. Sandes-Freitas1, L. Modelli de Andrade2, L. Requião-Moura3, J. Medina-Pestana3, H. Tedesco-Silva3, A. on behalf of Covid-19 KT Brazil Study Group1

  • The Impact Of Monoclonal Antibody Against Sars-CoV2 And Vaccination On Outcomes In Kidney Transplant Recipients With Covid-19

    N. M. Ali, V. Tatapudi, R. Chand, k. Sureau, S. Mehta, R. Montgomery

  • The Impact of Neutralizing Antibodies on Polyomavirus Infections in Mice

    D. R. Butcher, B. D. Thompson, H. K. Singh, V. Nickeleit

  • The Impact of New-Onset Diabetes After Transplantation on Survival and Major Cardiovascular Events in Korean Kidney Transplantation Recipients

    E. Kang1, J. Lee2, D. Kang3, Y. Jang4, S. Park5, Y. Kim4, D. Kim4, K. Joo4, Y. Kim4, M. Park6, Y. Lim7, H. Lee4

  • The Impact of Obesity on Delayed Graft Function

    B. Shi1, T. Ying2, J. Xu1, J. M. Laurence1, S. Chadban1

  • The Impact of Soluble Human Leukocyte Antigen (HLA) on Renal Antibody-Mediated Rejection (AMR) After Simultaneous Liver Kidney Transplantation (SLKT)

    H. Me1, A. Jaramillo1, D. Ramon1, L. G. Olsen1, R. Heilman1, H. Khamash1, T. Mohanakumar2, R. Ravichandran2

  • The Impact of T-Cell Receptor Diversity in Acute Kidney Transplant Rejection

    T. Sigdel1, P. Fields2, J. Liberto1, I. Damm1, M. Kerwin1, j. Hood2, P. Towfighi1, M. Sirota1, H. Robins2, M. M. Sarwal1

  • The Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation

    K. Evans1, K. Beermann1, H. Lee2, M. Harris1, C. W. Frankel3, H. Berry1, H. Ali3

  • The Impact of the New Allocation System of Kidney Transplantation on a Single Institution

    M. Eltemamy, Y. Lin, M. Khalil, S. Agrawal, V. Krishnamurthi, A. Wee

  • The Impact of Yttium-90 Radioembolization on T Cell Phenotypes in Bridged to Transplant Hepatocellular Carcinoma Patients

    K. Nunez, T. Sandow, P. Thevenot, A. Cohen

  • The Implication of Donor Race on the Post-Liver Transplant Prognosis of Patients with Nonalcoholic Steatohepatitis: Analysis of UNOS Database

    D. U. Lee1, J. Han2, J. Kwon2, K. Chang2, K. Lee2, G. Fan2, N. Urranaga1, D. Maluf3, C. Bhati1, K. Shetty1

  • The Intracellular Tacrolimus Concentration in CD3+ T Lymphocytes and CD14+ Monocytes and Its Association with Kidney Transplant Rejection

    S. Udomkarnjananun, C. Baan, B. de Winter, D. Hesselink

  • The Limited Role of Liver Transplantation in Porto-Pulmonary Hypertension Pathology

    J. Doi1, M. Fujiki2, S. Chaudhry1, T. Diago1, F. Aucejo1, C. Kwon1, B. Eghtesad3, C. Miller4, C. Quintini5, K. Hashimoto1

  • The Liver Regenerative Effect of Substance P After Major Hepatectomy in Rat Models

    H. Ahn1, H. Ko2

  • The Low Estimated Glomerular Filtration Rates at 6 and 12 Months After Living Kidney Transplantation Are Independent Risk for Graft Failure

    T. Hiramitsu1, T. Tomosugi2, K. Futamura2, O. Manabu1, N. Goto2, T. Ichimori2, S. Narumi2, Y. Watarai2

  • The Molecular Landscape of Bk Polyomavirus Infection in Kidney Transplant Recipients at Single Cell Resolution

    P. J. McCown, E. Farkash, F. Alakwaa, F. Eichinger, R. Menon, E. Otto, C. C. Berthier, K. J. Woodside, S. Norman, M. Kretzler, A. Naik

  • The Natural History of De Novo DSA After Kidney Transplantation

    C. López del Moral1, N. Lachmann2, S. Hergovits2, D. Stauch2, A. Akifova3, M. Naik3, B. Osmanodja3, D. Schmidt3, K. Budde3

  • The New Heart Allocation Policy Has Increased Listing by Exception

    J. R. Golbus1, Y. Ahn2, B. K. Nallamothu1, M. N. Walsh3, D. Zaun2, A. Israni2, M. Colvin1

  • The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma

    K. Sasaki1, S. Kimura2, K. Tomiyama3, Y. Bekki4, M. Murray3, P. Huang3, M. Fruscione2, A. Moro5, C. Kwon6

  • The Ontario Anatomic Kidney Score (OAKS) : Quantitative Macroscopic Assessment versus Histological Grading in Pre-transplant Evaluation of Donor Kidneys

    J. Mello Offerni1, D. Matty2, H. Abed3, P. Roshanov4, A. Sener1, P. Luke1

  • The Other Reasons for Waitlist Removal

    C. Martinez, J. Foutz, A. Placona, L. Cartwright

  • The Outcome of Clostridioides Difficile Infection in Hospitalized Intestinal Transplant Recipients

    W. Amjad1, T. Schiano2, A. Malik3, M. Segovia4, S. Jafri5

  • The Paradox of Lifestyle – Related Liver Disease: ASH and NASH

    N. Kemmer1, J. Buggs2

  • The Performance of the Kidney Donor Profile Index in Predicting Outcomes for Kidney Transplant Recipients of Standard Criteria Donors: Results from a Brazilian Single-Center Cohort Study

    A. Morais, R. D. Foresto, J. Medina-Pestana, H. Tedesco-Silva, L. R. Requião-Moura

  • The Perspective of General Nephrologists Toward Transitions of Care and Management of Patients with Failing Kidney Allografts

    T. Alhamad1, H. Murad1, D. Dadhania2, M. Pavlakis3, S. Parajuli4, B. P. Concepcion5, N. Singh6, N. Murakami7, M. Casey8, M. Ji1, M. Lubetzky9, E. Tantisattamo10, O. Alomar1, A. Faravardeh11, C. Blosser12, A. Basu13, M. Molnar14, G. Gupta15, J. T. Adler16, D. Adey17, K. J. Woodside18, R. Parsons13, K. Lentine19

  • The Post-operative Clinical Outcomes Of 59 Tanrp Cases In An International Cohort

    J. Louca1, N. Patel1, S. Messer2, J. Chindu2, S. Large2

  • The Pre-Transplant Non-HLA Antibody Burden Predicts the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation

    A. Senev1, B. Ray2, J. Hariharan2, C. Heylen2, M. Emonds1, M. Naesens1

  • The Prediction of Renal Allograft Rejection by Time-Dependent Two-Signature Predictors

    M. Liao1, Q. Fu2, L. Wei3, H. Yang3, G. Zhao3, S. Deng3, J. F. Markmann2

  • The Prevalence and Morbidity Associated with BK Virus in Heart Transplant Recipients

    A. Nguyen1, Z. Li2, N. F. Rasheed2, J. Cruz2, M. Fei3, G. Kim1, S. Pinney1, N. Uriel4

  • The Prevalence And Risk Factors Of De Novo Hepatitis B Virus Infection In Kidney Transplantation From Hepatitis B Antigen-positive Donors To Hbsag-negative Recipients

    J. Wu1, S. Yin1, F. Zhang1, L. Wu1, X. Wang2, T. Lin1

  • The Prevalence of Anti-SARS-CoV-2 Antibodies After COVID-19 is Similar in Kidney Transplant Recipients to Non-Transplanted Patients, and the Clinical Severity is a Predictor of Seroconversion

    L. R. Requião-Moura, R. Garcia, M. R. Nakamura, R. D. Foresto, V. Gomes, T. Ferreira, I. Meira, M. Cristelli, M. Jesus, R. Rissoni, E. Lucena, H. Tedesco-Silva, J. Medina-Pestana

  • The Price of Cold Ischemia Time

    A. Massie1, J. Scalea2, D. Segev1

  • The Promise Of Tolerance In Living Donor Kidney Transplant (LDKT): A Retrospective, Real-world Assessment Of The Safety And Efficacy Of LDKT With FCR001 Investigational Cell-therapy Compared With Standard Of Care (SOC)

    N. Krieger1, J. R. Leventhal2, B. Ho3, M. Richards4, D. Schaumberg4, S. Ildstad5, D. Axelrod6

  • The Relative Association of Clinical Variables and Histologic Lesions with Molecular Rejection in Kidney Transplant Biopsies

    M. L. Sikosana1, J. Reeve2, P. F. Halloran2, INTERCOMEX Investigators3

  • The Renin Angiotensin System (RAS) After Pig-to-Baboon Kidney Transplantation

    C. Hansen-Estruch1, M. H. Bikhet1, M. Javed1, D. Ayares2, A. Katsurada3, R. Satou3, W. Shao3, D. K. Cooper1, L. G. Navar3, E. Judd4

  • The Rise in the Number of Eligible Donors for Liver Transplantation Has Been Driven by an Exponential Increase in Marginal Donors

    C. Goff1, M. F. McDonald1, A. Anand1, K. Agahi1, J. Kahla1, A. Jang1, B. Martin1, Z. Shah1, S. Stockum1, R. Vopni2, J. A. Goss1, A. Rana1

  • The Role of Advanced Practice Providers in Liver Transplant Centers

    S. Nargiso, L. Sher, V. Tristan

  • The Role Of Combined Gene Expression Profiling And Donor-derived Cell-free Dna In Differentiating Acute Rejection In Liver Transplant Recipients

    S. Park1, M. Kandpal2, K. Guo2, S. Kleiboeker3, R. Sinha4, M. Abecassis5, J. Levitsky6

  • The Role of Donor Sex in Females Undergoing Repeat Kidney Transplant: Does Prior Donor Sex Matter?

    S. Craig1, K. Tennankore2, A. J. Vinson2

  • The Role Of Ferroptosis In Modulating Ischemia Reperfusion Injury(IRI) Gene Expression In Marginal Donor Livers(MDLS) Using The Novel Protect Normothermic Perfusion Pump

    M. D. Nazzal1, K. Kurashima2, J. Bettag2, A. Chen2, S. Bruno2, A. Nagarapu2, J. Van Nispen1, J. Krebs2, J. Teckman2, D. Carpenter3, D. Hermelin3, C. Varma1, A. Jain2

  • The Role of Gastrointestinal Pathogen PCR Testing in Liver Transplant Recipients Hospitalized with Diarrheal Illness

    C. K. Ching1, Y. R. Nobel2, M. R. Pereira3, E. C. Verna4

  • The Role of Geography in Adult Heart Allocation Over the Last 5 Years

    K. Bradbrook1, R. Goff1, R. Daly2, S. Hall3

  • The Role Of Gut Microbiome In Optimum Dose Selection Of Tacrolimus For Kidney Transplant Recipients

    M. Nayebpour1, N. Koizumi1, J. Melancon2

  • The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5

    M. Nayebpour1, N. Koizumi1, J. Melancon2, M. Hasan2

  • The Role of HNF4α in Renal Ischemia Reperfusion Injury

    A. D. Saha

  • The Role of LAG3 in Antibody Responses to Kidney Transplantation

    M. Nicosia1, R. Fan1, J. Lee2, V. Gorbacheva1, A. M. Beavers1, N. Dvorina1, W. Baldwin III1, R. L. Fairchild1, B. Min3, A. Valujskikh1

  • The Role of T Lymphocyte Subsets in Kidney Transplantation

    L. Vagiotas1, A. Xochelli2, E. Sampani3, V. Nikolaidou2, D. Asouchidou2, E. Kasimatis3, N. Antoniadis1, M. Daoudaki4, M. Stangou3, A. Papagianni3, G. Tsoulfas1, A. Fylaktou2

  • The Role of the Gut Microbiota in Pain Interference Before and After Kidney Transplantation: A Pilot Study

    M. B. Lockwood1, H. DeVon2, M. Maienschein-Cline1, G. Chlipala1, M. Samra3, A. Lichvar4, S. Green5

  • The Role of the Transversus Abdominis Plane (TAP) Block in Robotic Donor Nephrectomies

    A. -. Popovic1, J. Oehler2, S. Loerzel3, M. Hanlon3, S. Iskhagi3, E. Shaban4, R. H. Dvorai5, J. Leggat6, B. Gallay4, R. Saidi3, R. Shahbazov3

  • The Roles of Intrarenal B Cells in Regulating Antibody Mediated Rejection After Kidney Transplantation

    H. Zhang1, C. Cavazzoni1, E. Bechu1, B. Hanson1, M. A. Podestà1, D. Kreisel2, A. Alessandrini3, P. Sage1

  • The SHELTER Trial of Transplanting Donor Hepatitis C Virus RNA+ Lungs Into Uninfected Recipients

    V. Potluri1, P. Reese1, S. Prenner1, H. Mentch1, D. Goldberg2, T. Claridge1, J. Smith1, C. Gentile1, V. Van Deerlin1, R. Reddy1, T. Fallah1, C. Bermudez1, M. Crespo1, J. Diamond1

  • The Successful Use of De Novo Belatacept with Reduced Dose Tacrolimus to Mitigate the Risks of Delayed Graft Function in Kidney Transplantation

    E. Siskind1, J. Splinter1, C. Taing1, A. Adekile2, S. Njim1, S. Shah1, R. Plews3, D. Conti4, S. Patel2

  • The Sustained Impact of a Minimization Protocol on Peri-Operative Opioid Use in Kidney Transplantation

    N. Patel, T. Carcella, J. Marable, V. Rohan, S. Bethi, P. Baliga, D. Dubay, J. N. Fleming, D. Taber

  • The Ties That Transplant: The Social Network Determinants of the Living Kidney Donor Relationship Distribution

    J. Daw

  • The Trajectory of Donor-Derived Cell-Free DNA (dd-cfDNA) Complements the Baseline Measurements in Heart Transplant Surveillance for Rejection

    P. Shah1, R. Cheng2, H. Eisen3, B. D. Lowes4, L. Lourenco Jenkins5, Y. Fu5, K. Qu5, J. Teuteberg6, E. DePasquale7

  • The Unique Course of dd-cfDNA After Lung Transplant

    D. Levine1, C. Giner1, C. Pham2, R. Woodward3, A. Roux4

  • The US Kidney Allocation System Should Not Allocate En Bloc Kidneys from Deceased Donors < 18 Kg as Equivalent to Top 20% KDPI Single Kidneys

    W. F. Parker1, A. Gallo2, L. Ross1

  • The Use of Donor-Derived Cell-Free DNA in Female and Male Heart Transplant Recipients: A Sex-Specific Analysis of the Surveillance Heartcare Outcomes Registry

    E. M. DeFilippis1, Y. Fu2, R. Burke2, M. Deng3, M. Kamath4, L. Lourenco Jenkins2, A. R. Vest5

  • The Use of Frailty Assessment to Determine Fitness for Renal Transplant in a Veteran Dialysis Patient Population

    M. Samra1, A. Wadhwa1, T. Markossian2, R. Lopez-Soler3

  • Therapeutic Drug Monitoring of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Patients

    S. Sial, K. Cunningham, J. Moore, C. Dagostino, K. Lang, C. Kane

  • Third Dose of SARS-CoV-2 mRNA Vaccines Significantly Increases Delta (B.1.617.2) Variant Anti-Spike Antibody Levels in Kidney Transplant Recipients

    A. Al Jurdi1, R. B. Gassen1, T. Borges1, I. T. Lape1, L. Morena1, O. Efe1, Z. Solhjou2, R. El Fekih2, C. Kotton1, J. Azzi2, L. Riella1

  • Three Month Antibody Durability and Kinetics in Sars-cov-2 Mrna Vaccinated Heart and Lung Transplant Recipients: Differences Above the Diaphragm

    J. L. Alejo1, J. Ruck1, T. Chiang1, A. Abedon1, J. Kim1, R. Avery1, A. Tobian1, M. Levan1, D. Warren1, A. Massie1, W. Werbel1, J. Garonzik-Wang2, D. Segev1

  • Three-Way Comparison of Central DSA, %dd-cf DNA, and Molecular Biopsy Findings in the Trifecta Study

    P. F. Halloran1, L. G. Hidalgo2, Z. Demko3, A. Prewett3, J. Reeve1, C. Lawrence4, D. Lowe4, P. Billings3, .. and the Trifecta Investigators5

  • Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients

    M. Ji1, S. Chang1, M. Wang1, K. Lentine2, M. Merzkani1, H. Murad1, M. M. Ibrahim1, M. Zayed1, J. Wellen1, S. Sutcliffe1, T. Alhamad1

  • Thromboelastography in Liver Transplantation: A Target Group

    A. Mohamed1, T. Kitajima1, J. Cui1, S. Angappan2, K. Delvecchio1, T. Shamaa1, T. Ivanics3, S. Shimada1, M. Rizzari1, K. Collins1, A. Yoshida1, M. Abouljoud1, J. El-Bashir2, S. Nagai1

  • Thymoglobulin Induction Protocol: Quality Improvement Project via Clinical Audit

    S. Mouawad1, J. Dann1, A. Kumar2, S. Rao3

  • TIGIT Agonism Ameliorates Costimulation Blockade-Resistant Rejection by Increasing Quantity and Quality of Graft-Infiltrating Foxp3+ Treg

    C. R. Hartigan, D. Liu, S. Laurie, M. L. Ford

  • TIM-4 Identifies Proinflammatory B Cells Expressing an IL-23-Driven “Proinflammatory Module”

    Q. Ding1, V. Sola1, D. Rothstein2

  • Time-Dependent Blood Eosinophilia Count Increases the Risk of Kidney Allograft Rejection

    L. Colas1, L. Bui2, C. Kerleau3, M. Lemdani4, K. Autain-Renaudin5, A. Magnan6, M. Giral3, S. Brouard1

  • Timing of Hypotension Post Kidney Transplant Impacts the Risk of Subsequent Delayed Graft Function

    S. A. Morrison1, A. Thanamayooran2, K. Tennankore1, A. J. Vinson1

  • Tissue Edema Following Hypothermic Machine Perfusion of a Small Animal Hind Limb Graft

    D. Yoeli, Y. Wang, B. Li, J. Huang, S. Jain, Z. Wang, N. Nakra, N. Limon De La Rosa, K. Rampalski, A. Su, D. Mathes, K. Washington, E. Farkash, A. Jani, C. Huang

  • Tissue Engineering Scaffolds for Minimally Invasive Immunosurveillance of Acute Cellular Graft Rejection

    R. R. Urie1, D. Farris2, A. Morris1, E. Lombard1, J. Z. Li3, D. Goldstein2, L. Shea1

  • TNFRSF13B Genotype Determines the Properties of Donor-Specific B Cells

    M. Cascalho1, M. Garcia de Mattos Barbosa1, T. Pasieka1, E. Farkash2, R. Sung3, M. Doshi4, J. Platt4

  • TNX-1500, an Fc-Modified Anti-cd154 Antibody, Prolongs Nonhuman Primate Cardiac Allograft Survival

    S. Miura1, Z. Abady1, F. Pollok1, M. Ma1, K. Kinoshita1, S. Fogarty2, P. Maguire2, B. Daugherty2, S. Lederman2, R. Pierson III1

  • Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series

    B. Boonpheng1, R. Bakthavatsalam2, C. D. Blosser1, I. C. De Castro1, I. Gimferrer3, Y. Ng1, N. Leca1

  • Tolerance of Allogeneic Kidneys with Durable (>200 Days) Multilineage Chimerism and Bone Marrow Engraftment in Cynomolgus Macaques

    Y. Tomori1, Y. Hisadome1, D. Eisenson1, K. Takeuchi1, K. Okubo1, C. Huang2, D. Sachs1, M. Sykes1, K. Yamada1

  • Tolerant B Cells Suppress Memory B Cells in a Donor Specific Manner in CoB Mediated Transplantation Tolerance

    S. Durgam1, D. Yin1, M. Alegre2, A. Chong1

  • Toll-Like Receptor-4 Inhibitor, Resatorvid, Attenuates Allogenic T Cell Activation Against Human Pancreatic Islets by Decreasing CD69 Expression

    J. Mattke1, M. Plunk1, R. R. Kane1, B. Naziruddin2

  • Top Molecules Associated with CLAD in Lung Transplants Are Shared Between Mucosal Biopsies, Transbronchial Biopsies, and Kidney Transplant Biopsies at Risk of Progression

    M. Mackova1, K. Halloran2, P. F. Halloran1, .. and the INTERLUNG Study Group3

  • Towards Bionic Organs: Biocompatibility Of Newly Developed Porcine Decm-based Hydrogels.

    M. Rachalewski, M. Klak, D. Ujazdowska, P. Cywoniuk, T. Dobrzanski, G. Tymicki, K. Kosowska, T. Bryniarski, A. Berman, M. Wszola

  • Tracheostomy After Liver Transplantation: Utility and Impact

    D. Noguchi, V. M. Nguyen, C. J. Rosenthal, V. G. Agopian, D. G. Farmer, F. M. Kaldas

  • Tracking of Donor Reactive T Cell Clones Can Be Used to Diagnose or Even Predict Kidney Transplant Rejection

    J. M. Mathew1, Y. Sambandam1, M. Kandpal1, J. He1, G. Perottino1, B. Banbury2, P. Fields2, L. Gallon1, J. R. Leventhal1

  • Trajectory Analysis Of Single Cell RNAseq Data Suggest Intrarenal Induction Of Tregs In Spontaneously Accepted Kidney Allografts

    M. Guinn1, E. S. Szuter1, T. Yokose1, J. Ge2, B. Kwon1, I. Rosales3, P. S. Russell1, A. Cuenca2, J. Madsen1, R. Colvin3, A. Alessandrini1

  • Transbronchial Cryobiopsy vs Conventional Forceps Biopsy in Lung Transplant Recipients Multicenter Study

    M. Svorcova1, J. Vachtenheim1, J. Havlin1, P. Jakubec2, D. Rakita3, J. Balko4, J. Simonek1, J. Kolarik1, J. Pozniak1, R. Lischke1

  • Transition Program for Young Adults with Solid Organ Transplant a Single Center Protocol

    H. Y. Lee

  • Transitional-1 B Cell IL-10/TNFα Ratio Risk-Stratifies Renal Transplant Patients with Early Borderline Change

    A. Cherukuri, P. Randhawa, S. Hariharan, D. Rothstein

  • Transjugular Intrahepatic Portosystemic Shunt Placement is Associated with Increased All-Cause and Cardiac Mortality in Those Undergoing Liver Transplant for Nonalcoholic Steatohepatitis

    D. U. Lee1, J. Han2, J. Kwon2, K. Chang2, G. Fan2, K. Lee1, N. Urrunaga3, C. Bhati1, D. Maluf3, K. Shetty3

  • Transplant Centers That Assess Frailty as Part of Clinical Practice Have Better Outcomes

    X. Chen1, Y. Liu1, V. Thompson1, N. M. Chu1, E. A. King1, J. D. Walston2, J. A. Kobashigawa3, D. M. Dadhania4, D. L. Segev1, M. A. McAdams-DeMarco1

  • Transplant Combined with Neoadjuvant Therapy Improves Survival for Patients with Liver-Limited, Locally Advanced Intrahepatic Cholangiocarcinoma: A SEER Database Analysis

    G. G. Panayotova1, M. Javle2, S. Pentakota1, F. Paterno1, A. Amin1, L. Brown1, S. Simonishvili1, Y. Qin1, T. Ayorinde1, G. Prakash1, C. Conrad3, J. V. Guarrera1, K. E. Lunsford1

  • Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers

    K. Ko, C. Gregory, J. Le, A. Lutrick, U. Reddy

  • Transplant Graft TMA Injury Post COVID-19 Vaccination

    O. Sogbein, A. Rizvi, M. Mujtaba, S. Hussain

  • Transplant Patients Risk for SARS-CoV-2 Infection Post-2nd Vaccine Dose; We Are Not Home and Dry Yet

    G. Koimtzis1, L. Szabó1, P. Nagaraja1, C. Chalklin1, D. Elker2, A. Asderakis1

  • Transplant Rates Increased with Broader Distribution of Deceased Donor Kidneys

    A. Robinson1, K. Gauntt1, A. Wilk1, J. Kim2, V. Casingal3, N. Turgeon4, M. Pavlakis5

  • Transplantation of Hepatitis C Viremic Donor Organs to Hepatitis C Nonviremic Recipients: A Retrospective Review

    M. Leick, M. Blaha, M. Henry

  • Treading the Paradigm Shift: A Single Center Comparative Study of Outcomes Between Pre-Emptive and Early Kidney Transplant with Non Pre-Emptive Kidney Transplant Recipients Innational Kidney and Transplant Institute

    E. U. Go, L. Baloloy

  • Treatment Modality and Outcomes of Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients: The PARAMOUr Study

    R. Engen1, A. Jain2, N. Hayde3, A. Mansuri4, M. Kallash5, S. McEwen6, R. Garro7, C. Peterson8, R. Zahr9, L. Harshman10, D. Puliyanda11, S. Solomon12, K. Twombley13, I. Ashoor14

  • Treatment of BK Virus with Weekly Intravenous Immunoglobulin in Adult Kidney Transplant Recipients

    G. Girone1, W. Asch2

  • Treg Crosstalk with Both Tumor and Lymphatic Cells Promotes Metastasis Through Lta1b2-ltbr Signaling

    W. Piao1, R. S. Oakes2, C. M. Jewell2, J. Bromberg1

  • Treg Migration and Suppression Require Engagement with Lymphotoxin Beta Receptor on Lymphatic Endothelial Cells to Protect Islet Allografts

    V. Saxena1, W. Piao1, L. Li1, M. WillsonShirkey1, R. Lakhan1, S. Walden2, K. L. Hippen2, B. R. Blazar2, J. S. Bromberg1

  • Treg Tissue Stability Depends on Adenosine Receptor Driven Lymphatic Endothelial Cell Responses

    V. Saxena1, W. Piao1, L. Li1, M. W. Shirkey1, R. Lakhan1, S. Walden2, K. L. Hippen2, B. R. Blazar2, J. S. Bromberg1

  • Trends in Donor Cause of Death and the Effect on Outcomes in Liver Transplantation Over 15-Years

    J. A. Steggerda1, I. K. Kim2, D. P. Ladner1, J. Caicedo1, D. Borja-Cacho1

  • Trends in Donor Derived Cell Free DNA Before and After Cellular and Antibody Mediated Rejection

    K. Guo1, J. Friedewald1, C. Rebello1, B. Kinsella1, S. Park2, L. Zhao1

  • Trends in Prescribing Gabapentinoids, Co-Prescribed with Opioids or Benzodiazepines Among Kidney Transplant Recipients

    J. Ahn1, S. Bae1, J. Kim1, M. Schnitzler2, G. Hess3, K. Lentine2, D. Segev1, M. McAdams-DeMarco1

  • Trends of Living Kidney Donor Characteristics in the United States from 2000-2019

    N. K. Prabhu1, V. Villani1, K. P. Samy1, D. Sudan1, K. Ravindra1, W. Irish2

  • Trends on Organ Transplantation and Donation Based on Public Sentiments Expressed in Social Media Comments in Korea: Text Mining Analysis

    H. Ko, H. Ahn

  • Triple-Knockout Pig Red Blood Cells as Potential Sources for Blood Transfusion in Alloimmunized Patients with Sickle Cell Disease

    T. Yamamoto1, M. H. Bikhet2, H. Q. Nguyen2, Y. Cui2, M. Javed2, S. S. Raza2, D. Ayares3, H. Iwase2, H. Hara2, D. K. Cooper1

  • Tuberculosis (TB) Treatment without Rifampin in Kidney (K) and Kidney-Pancreas (KP) Transplantation (Tx)

    M. V. Radisic1, N. Pujato1, P. M. Bravo1, R. Del Grosso2, M. Hunter2, S. Beltramino3, L. Cornet1, R. Livia Franzini4, A. C. Dotta4, L. Leon4, J. Walther4, P. Uva5, G. Werber3, M. C. Rial4

  • Tuberculosis Screening Test Predicting Tuberculosis Infection in Solid Organ Transplant Recipients a Retrospective Cohort Study

    D. Alissa1, G. Korayem2, R. AlMaghrabi3, H. Alruwaisan3, F. Alyahya2, L. Aljuaid2, G. Alzimami2

  • Tumor Suppressor Role of the Caveolar α1-na/k-atpase Signalosome in Nash Related Hepatocellular Carcinoma (HCC)

    U. Udoh1, M. Banerjee1, J. D. Sanabria1, P. K. Rajan1, M. Schade2, J. A. Sanabria3, S. Pierre3, J. R. Sanabria4

  • Twelve Month Outcomes of Kidney Transplantation from Hepatitis C Viremic Deceased Donors to Aviremic Recipients

    L. A. Binari, R. C. Forbes, S. Rega, I. D. Feurer, A. Dreher, S. Shawar, H. Schaefer, D. Shaffer, B. P. Concepcion

  • Two Times or More Double-Filtration Plasmapheresis Increases the Risk of Bleeding During Kidney Transplantation

    T. Kanzawa, T. Tagisawa, M. Furusawa, K. Unagami, K. Kitajima, K. Omoto, H. Ishida, K. Tanabe, T. Takagi

  • Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes

    M. Lim1, K. Lee2

  • Type 1 Innate Lymphoid Cells Alleviate Acute Liver Injury Following Transplantation via Interferon-γ Mediated Pathway

    H. Kojima, K. Kadono, H. Hirao, K. J. Dery, J. Kupiec-Weglinski, Y. Zhai

  • Type 1 Innate Lymphoid Cells Are Critical Pro-Inflammatory Effector Cells in a Fatty Liver Mouse Model of Ischemia-Reperfusion Injury

    J. Kang, J. Liggett, K. Oza, Y. Cui, K. Loh, D. Kwon, B. Kallakury, T. Fishbein, W. Cui, K. Kahn, A. Kroemer

  • Type 1 Natural Killer T-cells: Key Mediators of Ischemia- Reperfusion Injury in Hepatic Steatosis

    J. R. Liggett1, J. Kang1, K. Loh1, K. Oza1, Y. Cui1, D. Kwon2, H. Li3, B. Kallakury2, T. Fishbein1, W. Cui1, K. Khalid1, A. H. Kroemer1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences